443 related articles for article (PubMed ID: 30409323)
1. Utilization of Transoral Robotic Surgery (TORS) in patients with Oropharyngeal Squamous Cell Carcinoma and its impact on survival and use of chemotherapy.
Baliga S; Kabarriti R; Jiang J; Mehta V; Guha C; Kalnicki S; Smith RV; Garg MK
Oral Oncol; 2018 Nov; 86():75-80. PubMed ID: 30409323
[TBL] [Abstract][Full Text] [Related]
2. Patterns of cervical node positivity, regional failure rates, and fistula rates for HPV+ oropharyngeal squamous cell carcinoma treated with transoral robotic surgery (TORS).
Cannon RB; Houlton JJ; Patel S; Raju S; Noble A; Futran ND; Parvathaneni U; Méndez E
Oral Oncol; 2018 Nov; 86():296-300. PubMed ID: 30409315
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of transoral robotic surgery for early-stage oropharyngeal squamous cell carcinoma with low rates of adjuvant therapy: A consecutive single-institution study from 2013 to 2020.
Meldgaard Justesen M; Kronberg Jakobsen K; Fenger Carlander AL; Hjordt Holm Larsen M; Wessel I; Kiss K; Friborg J; Ibrahim Channir H; Rubek N; Grønhøj C; von Buchwald C
Oral Oncol; 2024 May; 152():106783. PubMed ID: 38569317
[TBL] [Abstract][Full Text] [Related]
4. Primary surgery for human papillomavirus-associated oropharyngeal cancer: Survival outcomes with or without adjuvant treatment.
Cramer JD; Ferris RL; Kim S; Duvvuri U
Oral Oncol; 2018 Dec; 87():170-176. PubMed ID: 30527235
[TBL] [Abstract][Full Text] [Related]
5. Locoregional Recurrence in p16-Positive Oropharyngeal Squamous Cell Carcinoma After TORS.
Carey RM; Brody RM; Shimunov D; Shinn JR; Mady LJ; Rajasekaran K; Cannady SB; Lin A; Lukens JN; Bauml JM; Cohen RB; Basu D; O'Malley BW; Weinstein GS; Newman JG
Laryngoscope; 2021 Dec; 131(12):E2865-E2873. PubMed ID: 34076275
[TBL] [Abstract][Full Text] [Related]
6. Utility of up-front transoral robotic surgery in tailoring adjuvant therapy.
Gildener-Leapman N; Kim J; Abberbock S; Choby GW; Mandal R; Duvvuri U; Ferris RL; Kim S
Head Neck; 2016 Aug; 38(8):1201-7. PubMed ID: 27225507
[TBL] [Abstract][Full Text] [Related]
7. Differences in Functional and Survival Outcomes Between Patients Receiving Primary Surgery vs Chemoradiation Therapy for Treatment of T1-T2 Oropharyngeal Squamous Cell Carcinoma.
Amin DR; Philips R; Bertoni DG; Mastrolonardo EV; Campbell DJ; Agarwal AM; Tekumalla S; Urdang ZD; Luginbuhl AJ; Cognetti DM; Curry JM
JAMA Otolaryngol Head Neck Surg; 2023 Nov; 149(11):980-986. PubMed ID: 37422846
[TBL] [Abstract][Full Text] [Related]
8. Outcomes in surgically resectable oropharynx cancer treated with transoral robotic surgery versus definitive chemoradiation.
Dhanireddy B; Burnett NP; Sanampudi S; Wooten CE; Slezak J; Shelton B; Shelton L; Shearer A; Arnold S; Kudrimoti M; Gal TJ
Am J Otolaryngol; 2019; 40(5):673-677. PubMed ID: 31201038
[TBL] [Abstract][Full Text] [Related]
9. Clinical value of transoral robotic surgery: Nationwide results from the first 5 years of adoption.
Li H; Torabi SJ; Park HS; Yarbrough WG; Mehra S; Choi R; Judson BL
Laryngoscope; 2019 Aug; 129(8):1844-1855. PubMed ID: 30575965
[TBL] [Abstract][Full Text] [Related]
10. Oncologic outcomes and patient-reported quality of life in patients with oropharyngeal squamous cell carcinoma treated with definitive transoral robotic surgery versus definitive chemoradiation.
Ling DC; Chapman BV; Kim J; Choby GW; Kabolizadeh P; Clump DA; Ferris RL; Kim S; Beriwal S; Heron DE; Duvvuri U
Oral Oncol; 2016 Oct; 61():41-6. PubMed ID: 27688103
[TBL] [Abstract][Full Text] [Related]
11. Primary transoral robotic surgery with concurrent neck dissection for early stage oropharyngeal squamous cell carcinoma implemented at a Danish head and neck cancer center: a phase II trial on feasibility and tumour margin status.
Rubek N; Channir HI; Charabi BW; Lajer CB; Kiss K; Nielsen HU; Bentzen J; Friborg J; von Buchwald C
Eur Arch Otorhinolaryngol; 2017 May; 274(5):2229-2237. PubMed ID: 28050651
[TBL] [Abstract][Full Text] [Related]
12. Transoral robotic surgery for oropharyngeal squamous cell carcinoma in the era of human papillomavirus.
Mahmoud O; Sung K; Civantos FJ; Thomas GR; Samuels MA
Head Neck; 2018 Apr; 40(4):710-721. PubMed ID: 29244238
[TBL] [Abstract][Full Text] [Related]
13. Radiation therapy dose de-escalation compared to standard dose radiation therapy in definitive treatment of HPV-positive oropharyngeal squamous cell carcinoma.
Gabani P; Lin AJ; Barnes J; Oppelt P; Adkins DR; Rich JT; Zevallos JP; Daly MD; Gay HA; Thorstad WL
Radiother Oncol; 2019 May; 134():81-88. PubMed ID: 31005228
[TBL] [Abstract][Full Text] [Related]
14. Primary transoral robotic surgery +/- adjuvant therapy for oropharyngeal squamous cell carcinoma-A large observational single-centre series from the United Kingdom.
O'Hara J; Warner L; Fox H; Hamilton D; Meikle D; Counter P; Robson A; Goranova R; Iqbal S; Kelly C; Robinson M; Paleri V
Clin Otolaryngol; 2021 Sep; 46(5):1005-1012. PubMed ID: 33754476
[TBL] [Abstract][Full Text] [Related]
15. A Descriptive Study of Quality of Life Following Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.
Diaconescu A; Silver JA; Subramaniam T; Sewitch MJ; Mascarella MA; Ramirez-Garcia Luna J; Golabi N; Richardson K; Bouganim N; Forghani R; Marcin Mlynarek A; Hier MP; Sadeghi N
J Otolaryngol Head Neck Surg; 2024; 53():19160216241248670. PubMed ID: 38888957
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of HPV-Negative Oropharyngeal Cancer Treated With Transoral Robotic Surgery.
Jackson RS; Stepan K; Bollig C; Sharma RK; Patel M; Massa S; Puram SV; Zevallos JP; Pipkorn P; Zenga J
Otolaryngol Head Neck Surg; 2021 Nov; 165(5):682-689. PubMed ID: 33752484
[TBL] [Abstract][Full Text] [Related]
17. Survival and Swallowing Function after Primary Radiotherapy versus Transoral Robotic Surgery for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.
Hughes RT; Levine BJ; May N; Shenker RF; Yang JH; Lanier CM; Frizzell BA; Greven KM; Waltonen JD
ORL J Otorhinolaryngol Relat Spec; 2023; 85(5):284-293. PubMed ID: 37647863
[TBL] [Abstract][Full Text] [Related]
18. Survival and Gastrostomy Prevalence in Patients With Oropharyngeal Cancer Treated With Transoral Robotic Surgery vs Chemoradiotherapy.
Sharma A; Patel S; Baik FM; Mathison G; Pierce BH; Khariwala SS; Yueh B; Schwartz SM; Méndez E
JAMA Otolaryngol Head Neck Surg; 2016 Jul; 142(7):691-7. PubMed ID: 27347780
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of transoral laser microsurgery and transoral robotic surgery in oropharyngeal squamous cell carcinoma.
Sievert M; Goncalves M; Zbidat A; Traxdorf M; Mueller SK; Iro H; Gostian AO
Auris Nasus Larynx; 2021 Apr; 48(2):295-301. PubMed ID: 32883577
[TBL] [Abstract][Full Text] [Related]
20. Comparison of margins and survival between transoral robotic surgery (TORS) and non-robotic endoscopic surgery for oropharyngeal cancer.
Groysman M; Gleadhill C; Baker A; Wang SJ; Bearelly S
Am J Otolaryngol; 2023; 44(6):103982. PubMed ID: 37531886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
